• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Highmark Sells Medicare Claims Business to Prevent Conflict of Interest

Article

Highmark is selling its Medicare claims processing business to avoid any conflict-of-interest issues related to its purchase of West Penn Allegheny Health System (WPAHS). Blue Cross Blue Shield of Florida's subsidiary, Diversified Service Options, is buying Highmark Medicare Services (HMS) for an undisclosed sum.

"This change was prompted by Highmark's provider strategy," Highmark Vice President David O'Brien said in a statement. "The decision was a difficult one, but one which best positions HMS to maintain its current business and pursue its government business growth strategy."

HMS processes Medicare claims for the federal government in Pennsylvania, New Jersey, Maryland, Delaware and the District of Columbia. If Highmark didn't sell HMS, it would have owned a hospital that bills Medicare as well as a company that processes those claims, which violates federal requirements, reports the Pittsburgh Business Times.

Although HMS generated about $100 million in revenue, Highmark said selling the company won't impact the insurer's bottom line.

Read the full story at: http://tinyurl.com/7je67gb

To learn more:

Pittsburgh Business Times: http://tinyurl.com/6ql3djo

Pittsburgh Post-Gazette: http://tinyurl.com/7uy8vmd

Source: Fierce Health Payer

Related Videos
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Amit Singal, MD, UT Southwestern Medical Center
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Rashon Lane, PhD, MA
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Beau Raymond, MD
Binod Dhakal, MD, Medical College of Wisconsin, lead CARTITUDE-4 investigator
Dr Sophia Humphreys
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.